Rilpivirine in HIV-1-positive women initiating pregnancy: to switch or not to switch?

The Journal of Antimicrobial Chemotherapy
Pierre FrangeANRS EPF CO1/CO11 Study Group

Abstract

Safety data about rilpivirine use during pregnancy remain scarce, and rilpivirine plasma concentrations are reduced during second/third trimesters, with a potential risk of viral breakthroughs. Thus, French guidelines recommend switching to rilpivirine-free combinations (RFCs) during pregnancy. To describe the characteristics of women initiating pregnancy while on rilpivirine and to compare the outcomes for virologically suppressed subjects continuing rilpivirine until delivery versus switching to an RFC. In the ANRS-EPF French Perinatal cohort, we included women on rilpivirine at conception in 2010-18. Pregnancy outcomes were compared between patients continuing versus interrupting rilpivirine. In women with documented viral suppression (<50 copies/mL) before 14 weeks of gestation (WG) while on rilpivirine, we compared the probability of viral rebound (≥50 copies/mL) during pregnancy between subjects continuing rilpivirine versus those switching to RFC. Among 247 women included, 88.7% had viral suppression at the beginning of pregnancy. Overall, 184 women (74.5%) switched to an RFC (mostly PI/ritonavir-based regimens) at a median gestational age of 8.0 WG. Plasma HIV-1 RNA nearest delivery was <50 copies/mL in 95.6% of women. ...Continue Reading

References

Dec 22, 2007·AIDS·Josiane WarszawskiUNKNOWN ANRS French Perinatal Cohort
Mar 31, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jeanne SibiudeLaurent Mandelbrot
Jul 23, 2015·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Laurent MandelbrotUNKNOWN ANRS-EPF Study Group
Feb 9, 2016·AIDS·Mira HleyhelUNKNOWN ANRS French Perinatal Cohort Study Group
Feb 27, 2016·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Anna H TranUNKNOWN IMPAACT P1026s Protocol Team
Nov 3, 2016·The New England Journal of Medicine·Mary G FowlerUNKNOWN IMPAACT 1077BF/1077FF PROMISE Study Team
Jun 9, 2017·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Stein SchalkwijkUNKNOWN Pharmacokinetics of newly developed antiretroviral agents in HIV-infected pregnant women (PANNA) Network
Aug 8, 2017·JAMA Pediatrics·Rebecca ZashRoger L Shapiro
Nov 15, 2017·AIDS·Graziella FavaratoClaire Thorne
Mar 13, 2018·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Ahizechukwu C EkeUNKNOWN IMPAACT P1026s Protocol Team
Dec 21, 2018·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Begoña Martinez de Tejada, UNKNOWN European Pregnancy and Paediatric HIV Cohort Collaboration Study Group
Jan 17, 2019·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Violaine PeyronnetLaurent Mandelbrot
Jul 23, 2019·The New England Journal of Medicine·Rebecca ZashRoger L Shapiro

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.